Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7370 p429-436
8 October 2005

This section
Reprint   Photocopy

PDF 750K, Acrobat Reader

News summary including R&D

DIARY   Branch meetings   Future Events   Conferences

429 Trusts cannot afford to implement Agenda for Change Evidence that NHS trusts are abusing the job evaluation process because they claim they cannot afford to implement Agenda for Change has been highlighted by Amicus, the trade union that represents hospital pharmacists ...more

429 School of Pharmacy researcher wins photographic contest David McCarthy, head of the electron microscope unit at the School of Pharmacy, University of London, has received first prize for his image of a salt grain and a peppercorn in the 2005 Novartis and The Daily Telegraph Visions of Science photographic awards ...more

429 Atomoxetine associated with risk of suicidal behaviour, warns CSM Atomoxetine (Strattera) has been associated with an increased risk of suicidal thoughts or behaviour in children and adolescents, the Committee on Safety of Medicines has warned ...more

430 Hospital drugs account for 22.3pc of NHS drug’s bill Hospital pharmacies are responsible for 22.3 per cent of the total NHS drug’s bill in England, according to official figures ...more

430 Scottish prescription volume and cost rise More NHS prescriptions than ever are being dispensed in the community in Scotland ...more

430 BNF 50 now available BNF 50, the latest edition of the British National Formulary, contains updated information on malaria prophylaxis, the use of tricyclic antidepressants and advice on vaccinations ...more

430 UK below average in Europe for uptake of new cancer drugs The UK is one of the worst countries in Europe in terms of patient access to new cancer drugs ...more

431 Alliance UniChem and Boots announce merger plans Alliance UniChem and Boots have announced plans to merge into a £7bn pan-European company to be called Alliance Boots ...more

431 Boots weight loss programme rolled out A weight loss programme that includes access to orlistat (Xenical) via a private patient group direction is being rolled out across 100 Boots The Chemists pharmacies ...more

431 Clinical governance survey The National Audit Office wants to examine whether primary care trusts in England are achieving improvements in patient care through better clinical governance ...more

431 Influenza campaign launched The Department of Health’s influenza campaign was launched this week ...more

432 Independent Pharmacy Federation launched A new organisation exclusively to represent the interests of independent community pharmacists across the UK has been launched ...more

432 Industry funds pharmacist and pharmacy student training Funds from the pharmaceutical industry are being used to support the professional development of pharmacists, pharmacy students and other health professionals as well as helping to boost the care of patients with chronic disease ...more

432 NHS counter fraud strategy published for Scotland Tackling fraud in NHS Scotland is the subject of a new strategy launched by the Scottish Executive ...more

433 Global chronic disease needs to be tackled, says WHO Chronic diseases are responsible for around 17 million premature deaths per year worldwide, according to a World Health Organization report ...more

433 Patients need support in taking statins effectively Policy makers should consider how to support patients in taking statins effectively, according to the Task Force on Medicines Partnership ...more

433 Injection frequency does not affect treatment satisfaction Patients’ treatment satisfaction is not affected by whether injections are once- or twice-daily ...more

433 Parallel importers call for “market” to be redefined European competition rules need to be changed to ease parallel trade in pharmaceuticals, the European Association of Euro-Pharmaceutical Companies has said ...more

433 Welsh children’s NSF sets training standards Minimum training standards for pharmacy curriculums have been specified in the Welsh National Service Framework for Children, Young People and Maternity Services ...more

434 Link found between amoxicillin and enamel defects Amoxicillin use during infancy has been linked to the development of enamel defects in permanent teeth ...more

434 Charity appeals to pharmacists to help educate public about mouth cancer The British Dental Health Foundation is appealing to pharmacists to help educate the public about symptoms of mouth cancer in the run up to its annual mouth cancer awareness campaign ...more

434 Nobel prize awarded for bacterium link to ulcers Proving that infection by the bacterium Helicobacter pylori, and not stress and lifestyle, causes peptic ulcer disease has won Barry Marshall, of the University of Western Australia, and Robin Warren, formerly a pathologist at Royal Perth Hospital, Australia, the 2005 Nobel Prize in Physiology or Medicine ...more

435 Pharmacy diabetes network “smartgroup” launched A network of pharmacists and pharmacy technicians with an interest in diabetes is set to grow with the launch of a Diabetes UK “smartgroup” ...more

435 Patients advised to alert their doctors if pharmacists switch their epilepsy drug Patients with epilepsy should alert their doctors if pharmacists switch their medicine from a branded to a generic product or vice versa ...more

435 Funding announced for pharmacists to undertake management of drug misuse training Funding is available for pharmacists in Scotland to undertake training in the management of drug misuse in primary care ...more

435 Levetiracetam now licensed in children Levetiracetam (Keppra) is now licensed for the treatment of children with epilepsy, following European approval ...more

436 Antirheumatic drug with novel mechanism of action Abatacept, the first in a new class of antirheumatic drugs called selective co-stimulation modulators, appears to offer pain relief and increased mobility in rheumatoid arthritis patients ...more

436 Aspirin may protect against cardiac effects of COX-2 inhibitors, say researchers A chemical imbalance that may be corrected with aspirin therapy, could underlie the cardiovascular side effects of cyclo-oxygenase-2 inhibitors ...more

436 DPP-IV inhibitor better tolerated than metformin Vildagliptin, a dipeptidyl peptidase-IV inhibitor, is better tolerated than metformin and achieves similar sustained reductions in HbA1c levels ...more

436 Yeast may be an option for nasal delivery of insulin Applying a solution of yeast to a monolayer of epithelial cells increases the transport of insulin through it ...more

436 Pomegranate juice Pomegranate juice has been shown to reduce prostate tumour growth and levels of prostate specific antigen in mice ...more

Back to Top


©The Pharmaceutical Journal